Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for non-small cell lung cancer.

Rendell W Ashton1, James R Jett

  • 1Pulmonary Medicine and Medical Oncology, Mayo College of Medicine, 200 1st St SW, Rochester, MN 55905, USA. Ashton.Rendell@mayo.edu

Seminars in Oncology
|July 1, 2005
PubMed
Summary

Lung cancer screening aims for early detection, but current methods lack proven mortality benefits. Ongoing trials with new techniques like low-dose CT are investigating effectiveness for lung cancer survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a blood-based autoantibody test to assess lung cancer risk in 4-30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies.

Future oncology (London, England)·2026
Same author

Reply to Helmers <i>et al.</i>: Beyond Evaluation: Resisting Quantification in the Medical Humanities.

ATS scholar·2025
Same author

Evaluation of a Narrative Medicine Workshop for Pulmonary Critical Care Fellows.

ATS scholar·2025
Same author

The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non-small cell lung cancer.

Cancer·2024
Same author

The Intersection of Lung Cancer Screening, Radiomics, and Artificial Intelligence: Can One Scan Really Predict the Future Development of Lung Cancer?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

The Virtual Interview Experience: Perspectives of Pulmonary and Critical Care Fellowship Applicants.

ATS scholar·2022

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Imaging

Background:

  • Lung cancer remains a leading cause of cancer mortality worldwide.
  • Late-stage diagnosis often limits treatment efficacy.
  • Current screening strategies have not demonstrated a significant mortality benefit.

Purpose of the Study:

  • To review the current status of lung cancer screening.
  • To discuss emerging screening technologies and their potential.
  • To emphasize the importance of ongoing research and clinical trials.

Main Methods:

  • Review of existing literature on lung cancer screening trials.
  • Discussion of novel screening modalities such as low-dose computed tomography (CT), autofluorescence bronchoscopy, and sputum analysis.
  • Highlighting the need for controlled, randomized trials.

Main Results:

  • No lung cancer screening trials have definitively shown a mortality benefit to date.
  • Newer methods, particularly low-dose CT, show promise in detecting early-stage lung cancer.
  • Published data on newer methods often lack control groups and mortality data.

Conclusions:

  • Major medical organizations do not currently recommend lung cancer screening due to lack of proven mortality benefit.
  • Further research, including well-designed randomized controlled trials, is crucial.
  • Encouraging patient participation in clinical trials is vital for advancing lung cancer screening research.

Related Experiment Videos